Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-20-001288
Filing Date
2020-05-21
Accepted
2020-05-21 20:29:05
Documents
1
Period of Report
2020-05-11

Document Format Files

Seq Description Document Type Size
1 form3-05212020_050551.html 3  
1 form3-05212020_050551.xml 3 4089
  Complete submission text file 0001415889-20-001288.txt   5527
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 157 TECHNOLOGY DR IRVINE CA 92618
Business Address
MAIDA ANTHONY E III (Reporting) CIK: 0001273213 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 20903427